Partnerships

Translational Development Partnerships

Decinova’s partner capability is grounded in hands-on cell-therapy development experience built through DSC. Alongside the DSC platform, Decinova offers a focused set of partnership routes — not full-service ATMP development, CMC execution, GMP manufacturing or regulatory-submission services.

Conceptual illustration of research, cell-therapy manufacturing, investment, global networks and regulatory quality converging on a Decidua stromal-cell therapeutic product.

Partnership Opportunities

Ways to Partner With Decinova

DSC Platform Licensing & Co-Development

Global or regional licensing and co-development structures to advance the DSC platform in SR-aGVHD and its broader potential.

Start a licensing conversation →

Regional Development & Market-Access

Discussions on regional development and market-access strategy for the DSC platform in specific territories, grounded in the platform’s translational and regulatory history.

Discuss regional development →

Scientific & Translational Program Assessment

Decinova can support selected partner programs through scientific assessment and translational-development perspective, grounded in hands-on cell-therapy development experience.

Propose a collaboration →

Technology-Transfer Strategy

Development-strategy and technology-transfer planning for Decinova’s stromal-cell and cell-technology know-how into a partner’s own setting.

Discuss technology transfer →

Looking for paid development or technology-build support for your own program rather than a DSC partnership? Visit Technology Development.

Let’s Move Cell Therapy Forward.

Tell us about your organization and the type of partnership you’re exploring — we’ll route it to the right conversation.